Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients

References

• Metts MC, Metts JC, Milito SJ, Thomas CR Jr. Bladder cancer: a review of diagnosis and management. J Natl Med Assoc 2000; 92:285 - 94; PMID: 10918764
   PubMed Web of Science ®Google Scholar
• Utz DC, Farrow GM. Management of carcinoma in situ of the bladder: the case for surgical management. Urol Clin North Am 1980; 7:533 - 41; PMID: 7456165
   PubMed Web of Science ®Google Scholar
• Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 1976; 116:180 - 3; PMID: 820877
   PubMed Web of Science ®Google Scholar
• Schenk-Braat EA, Bangma CH. Immunotherapy for superficial bladder cancer. Cancer Immunol Immunother 2005; 54:414 - 23; http://dx.doi.org/10.1007/s00262-004-0621-x; PMID: 15565330
   PubMed Web of Science ®Google Scholar
• Totterman TH, Loskog A, Essand M. The immunotherapy of prostate and bladder cancer. BJU Int 2005; 96:728 - 35; http://dx.doi.org/10.1111/j.1464-410X.2005.05772.x; PMID: 16144528
   PubMed Web of Science ®Google Scholar
• Bisiaux A, Thiounn N, Timsit MO, Eladaoui A, Chang HH, Mapes J, et al. Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer. J Urol 2009; 181:1571 - 80; http://dx.doi.org/10.1016/j.juro.2008.11.124; PMID: 19230924
   PubMed Web of Science ®Google Scholar
• Bredan R, Bisiaux A, Biot C, Rentsch CA, Bousso P, Albert ML. Mathematical model of tumor immunotherapy for bladder carcinoma identifies the limitations of the innate immune response. OncoImmunology 2012; 1:9 - 17; http://dx.doi.org/10.4161/onci.1.1.17884
   Google Scholar
• Ratliff TL. Role of the immune response in BCG for bladder cancer. Eur Urol 1992; 21:Suppl 2 17 - 21; PMID: 1396942
   PubMedGoogle Scholar
• Stachowski J, Barth C, Lewandowska-Stachowiak M, Lammerding P, Runowski D, Baldamus CA. Flow cytometric analysis of urine lymphocytes isolated from patients with renal transplants--purification of urine lymphocytes. J Immunol Methods 1998; 213:145 - 55; http://dx.doi.org/10.1016/S0022-1759(98)00013-1; PMID: 9692847
   PubMed Web of Science ®Google Scholar
• de Boer EC, de Jong WH, van der Meijden AP, Steerenberg PA, Witjes F, Vegt PD, et al. Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis. Urol Res 1991; 19:45 - 50; http://dx.doi.org/10.1007/BF00294021; PMID: 2028562
   PubMed Web of Science ®Google Scholar
• De Boer EC, De Jong WH, Van Der Meijden AP, Steerenberg PA, Witjes JA, Vegt PD, et al. Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin. Cancer Immunol Immunother 1991; 33:411 - 6; http://dx.doi.org/10.1007/BF01741603; PMID: 1878894
   PubMed Web of Science ®Google Scholar
• Derré L, Jandus C, Baumgaertner P, Posevitz V, Devêvre E, Romero P, et al. Quantitative multiparameter assays to measure the effect of adjuvants on human antigen-specific CD8 T-cell responses. Methods Mol Biol 2010; 626:231 - 49; http://dx.doi.org/10.1007/978-1-60761-585-9_16; PMID: 20099132
   PubMedGoogle Scholar
• Brunst M, Shahmanesh M, Sukthankar A, Pearce JH, Gaston JS. Isolation and characterisation of T lymphocytes from the urethra of patients with acute urethritis. Sex Transm Infect 1998; 74:279 - 83; http://dx.doi.org/10.1136/sti.74.4.279; PMID: 9924470
   PubMed Web of Science ®Google Scholar
• Siracusano S, Vita F, Abbate R, Ciciliato S, Borelli V, Bernabei M, et al. The role of granulocytes following intravesical BCG prophylaxis. Eur Urol 2007; 51:1589 - 97, discussion 1597-9; http://dx.doi.org/10.1016/j.eururo.2006.11.045; PMID: 17222501
   PubMed Web of Science ®Google Scholar
• Suttmann H, Riemensberger J, Bentien G, Schmaltz D, Stöckle M, Jocham D, et al. Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses. Cancer Res 2006; 66:8250 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-06-1416; PMID: 16912205
   PubMed Web of Science ®Google Scholar
• Brandau S, Trellakis S, Bruderek K, Schmaltz D, Steller G, Elian M, et al. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 2011; 89:311 - 7; http://dx.doi.org/10.1189/jlb.0310162; PMID: 21106641
   PubMed Web of Science ®Google Scholar
• Moodie Z, Price L, Gouttefangeas C, Mander A, Janetzki S, Löwer M, et al. Response definition criteria for ELISPOT assays revisited. Cancer Immunol Immunother 2010; 59:1489 - 501; http://dx.doi.org/10.1007/s00262-010-0875-4; PMID: 20549207
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A, Roosnek E, Gregory T, Berman P, Abrignani S. T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature 1988; 334:530 - 2; http://dx.doi.org/10.1038/334530a0; PMID: 2841610
   PubMed Web of Science ®Google Scholar
• Decrausaz L, Revaz V, Bobst M, Corthésy B, Romero P, Nardelli-Haefliger D. Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice. Int J Cancer 2010; 126:2469 - 78; PMID: 19816937
   PubMed Web of Science ®Google Scholar
• Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der Hulst JM, Drijfhout JW, et al. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res 2007; 67:354 - 61; http://dx.doi.org/10.1158/0008-5472.CAN-06-3388; PMID: 17210718
   PubMed Web of Science ®Google Scholar
• Revaz V, Debonneville A, Bobst M, Nardelli-Haefliger D. Monitoring of vaccine-specific gamma interferon induction in genital mucosa of mice by real-time reverse transcription-PCR. Clin Vaccine Immunol 2008; 15:757 - 64; http://dx.doi.org/10.1128/CVI.00392-07; PMID: 18367582
   PubMed Web of Science ®Google Scholar